how long have glp-1 drugs been around receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal glp 1 receptor agonists

how long have glp-1 drugs been around receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal glp 1 receptor agonists

glp 1 receptor agonists are contraindicated in What the contraindications to Glucagon-like peptide-1 (GLP-1) agonists? The Impact of GLP-1 Receptor –

While obesity itself significantly increases venous thromboembolism risk, current evidence shows these injections do not add to that risk and may actually improve cardiovascular health through weight reduction

Some patients, termed “super-responders,” lose more weight than expected